The global renal biomarker market is predicted to be valued at US$ 1,541.2 million by 2024. The market valuation is estimated to be US$ 3,031.8 million by 2034, projected at a CAGR of 7%. Rise in the prevalence of chronic kidney diseases (CKD) globally propels the demand for biomarker-based diagnostic solutions to facilitate early detection …